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Abstract
The type III secretion system (T3SS) is essential in the pathogenesis of Yersinia pestis, the 
causative agent of plague. A small protein, LcrG, functions as a chaperone to the tip protein LcrV, 
and the LcrG-LcrV interaction is important in regulating protein secretion through the T3SS. The 
atomic structure of the LcrG family is currently unknown. However, because of its predicted 
helical propensity, many have suggested that the LcrG family forms a coiled-coil structure. Here, 
we show by NMR and CD spectroscopy that LcrG lacks a tertiary structure and it consists of three 
partially folded alpha helices spanning residues 7-38, 41-46, and 58-73. NMR titrations of LcrG 
with LcrV show that the entire length of a truncated LcrG (residues 7-73) is involved in binding to 
LcrV. However, there is regional variation in how LcrG binds to LcrV. The C-terminal region of a 
truncated LcrG (residues 52-73) shows tight-binding interaction with LcrV while the N-terminal 
region (residues 7-51) shows weaker interaction with LcrV. This suggests there are at least two 
binding events when LcrG binds to LcrV. Biological assays and mutagenesis indicate that the C-
terminal region of LcrG (residues 52-73) is important in blocking protein secretion through the 
T3SS. Our results reveal structural and mechanistic insights into the atomic conformation of LcrG 
and how it binds to LcrV.
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INTRODUCTION
Pathogenesis of Yersinia pestis requires the assembly of the type III secretion system (T3SS) 
to inject Yops (Yersinia outer proteins) into macrophages and other phagocytes to disable 
the host immune response against infection [1,2]. There are three components of the T3SS – 
(i) structural proteins that assemble into a nanoinjector-like devise consisting of a base, an 
external needle, and a tip complex; (ii) effector proteins that are injected into the host cells 
to modulate their response to bacterial infection; and (iii) chaperone proteins that bind 
structural and effector proteins prior to secretion [3–6]. In Y. pestis, the tip complex is 
formed by several copies of LcrV (320 residues) [7]. Prior to secretion, the tip protein LcrV 
is chaperoned by a smaller protein, LcrG (95 residues) [8,9].
LcrG interacts with LcrV [8–14] with nanomolar binding affinity (kd = 140 nM by SPR) 
[12]. The N-terminus of LcrG is involved in the binding interaction with LcrV based on 
results from yeast two hybrid assays [13]. The tight binding interaction of LcrG with LcrV is 
involved in regulating Yop secretion [15–17]. LcrG functions as a negative regulator of 
secretion as increased levels of LcrG block Yop secretion [9,16]. The crystal structures of 
LcrV [18,19] show an overall “dumbbell-shaped” molecule with a central coiled-coil 
connecting an N-terminal globular domain and a less structured mixed α/β domain. 
However, the atomic structure of LcrG or any member of the LcrG family of tip chaperones 
(Fig. 1) is unknown as well as the atomic structure of the LcrG-LcrV. The predicted helical 
propensity of LcrG (Fig. 1) led others to suggest that LcrG forms a coiled-coil [12,20] and 
that binding to LcrV involves an LcrG coiled-coil [12]. Others suggested that binding to 
LcrV involves the formation of an LcrG alpha-helical hairpin [21]. Recently, Basu et al. [22] 
reported a 3D coiled-coil structure for the LcrG homolog in Pseudomonas aeruginosa, 
PcrG, derived by computational modeling. Thus, the current understanding in the literature 
is that the LcrG family of proteins has a three-dimensional coiled-coil structure [12,20,22].
Here, we show by NMR that unbound LcrG lacks a tertiary structure and that it contains 
only two partially formed alpha helices. We show that the entire length of LcrG residues 
7-73 is involved in binding LcrV. We also identify a short region of LcrG from residues 
52-73 that forms a tight interaction with LcrV, while the rest of LcrG residues 7-51 is 
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involved in weaker interactions with LcrV, suggesting there are at least two binding events 
when LcrG binds LcrV.
RESULTS
Expression and purification of LcrG
Secondary structure prediction using PSIPRED [23] suggested that the LcrG family of tip 
protein chaperones was predominantly helical in secondary structures (Fig. 1). Based on the 
predicted secondary structures of LcrG (Fig. 1), three constructs were expressed and purified 
for structural characterization: (i) the full length LcrG (LcrGFL, 95 amino acids), (ii) a 
truncated form spanning residues 7-73 (LcrG7-73) that eliminated the predicted random coil 
regions at the amino and carboxy termini of LcrG, and (iii) a C34S point mutation 
engineered into LcrG7-73 (herein referred to as LcrG*). These three LcrG constructs were 
expressed in soluble forms in E. coli as GB1 fusion proteins, digested with tobacco etch 
virus (TEV) protease and purified under native conditions generating millimolar amounts of 
purified proteins.
CD spectroscopy
Results of CD spectroscopy confirmed the predominantly helical secondary structure of 
LcrG (Fig. 2). CD spectra of LcrGFL, LcrG7-73 and LcrG* showed that the LcrG constructs 
were primarily α-helical in secondary structure as indicated by the characteristic minima at 
222 and 208 nm. The ratios of ellipticities at 222 and 208 nm (θ222/θ208 ) were 0.8 for 
LcrGFL and LcrG7-73; and 0.7 for LcrG*, which suggested non-interacting alpha helices 
[24,25] in contrast to θ222/θ208 ratio of 1.0 found in helical bundles and coiled-coils [26,27] 
with extensive interhelical contacts. Comparison of all three CD spectra confirmed that 
LcrGFL and LcrG7-73 had nearly identical secondary structures, and that the C34S mutation 
did not significantly alter the secondary structure of LcrG (Fig. 2). CD thermal denaturation 
curves of LcrGFL, LcrG7-73 and LcrG* showed that all three proteins unfolded in a non-
cooperative manner without displaying a clear inflection point (Fig. 2). Overall, the CD data 
suggests the presence of non-interacting alpha helices in LcrG, or in other words, that LcrG 
contains secondary structures but lacks a tertiary fold.
NMR spectroscopy
NMR spectroscopy was used to identify the helical regions of LcrG. Full length LcrG 
(LcrGFL) showed poor quality 2D 1H-15N HSQC spectrum (Fig. 3a) that was characterized 
by overlapped peaks; poor dispersion and resolution; and less peaks than expected for a 95-
residue protein. The poor quality of the 15N HSQC of LcrGFL made it unsuitable for further 
NMR characterization. We reasoned that the poor quality of the NMR spectrum of LcrGFL 
could be due to the presence of a native cysteine at position 34 that might form disulfide 
linkages and contribute to the aggregation of the protein, which could result in the 
broadened peaks seen in Fig. 3a. Mutation of C34 into serine somewhat improved the NMR 
spectrum (Fig. 3b), however the 2D 1H-15N HSQC spectrum of LcrGFL C34S was also non-
ideal for further NMR characterization because of the significant number of overlapping 
peaks and conformational heterogeneity (Fig. 3b), which possibly arose from the cis-trans 
isomerization of the prolines present in the flexible C-terminal tail of LcrG. Truncation of 
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the predicted disordered tails to form the LcrG7-73 construct improved the 2D 1H-15N HSQC 
spectrum but did not result in an ideal NMR spectrum either. Only 58% of the residues in 
the protein were represented in the 2D 1H-15N HSQC spectrum of LcrG7-73 and the peaks 
were broad and poorly resolved (Fig. 3c). Mutation of C34 in the LcrG7-73 construct to 
alanine (Fig. 3d) or serine (Fig. 4) significantly improved the quality of the NMR data; 
however, the 2D 1H-15N HSQC spectrum of the C34A mutant (Fig. 3d) still exhibited broad 
and overlapping peaks. In contrast, the C34S mutation yielded an excellent quality 
2D 1H-15N HSQC spectrum with sharp and well-resolved peaks (Fig. 4). Thus, LcrG* (or 
LcrG7-73 C34S ) was deemed the best construct for further NMR characterization.
NMR backbone assignments
Three-dimensional NMR datasets were acquired using 15N/13C LcrG* for backbone 
resonance assignments. Of the 67 backbone amides of LcrG*, 62 were assigned (Fig. 4). 
The backbone amides of H25, R26, E32, M45, and K46 could not be assigned due to rapid 
solvent exchange or exchange dynamics on the us-ms time scale. The overlapping peaks are 
indicated in Fig. 4 with asterisks. The backbone resonances of I37, I47, and F48 were 
assigned by 15N amino acid specific labeling and by introducing an I37A point mutation in 
LcrG*.
The secondary 13Cα and 13Cβ chemical shifts of LcrG* suggested three α-helical regions 
spanning residues 7-38, 41-46, and 58-73 (designated helix α1-α3 in Fig. 5). Regions with 
consecutive residues of positive 13Cα secondary chemical shifts were assigned as alpha 
helical [28]. Helix α1 showed somewhat lower 13Cα secondary chemical shifts compared to 
helix α2 and α3. The helices were linked by a short 2-residue linker (residue 39-40) between 
helix α1 and helix α2 and a 10-residue linker (residue 47-56) between helix α2 and α3. 
Although residue 57 near helix α3 showed a positive 13Cα secondary chemical shift, we 
assigned helix α3 to begin with a proline residue, P58, because a proline being a helix 
breaker is less likely found within a helix but can be found at the beginning of a helix [29]. 
Likewise, helix α2 begins with another proline, P41. Using the method of Eliezer et al. [30] 
in estimating the fractional helicity based on 13Cα secondary chemical shifts and assuming a 
simple (unfolded ↔ folded) two state model and a 13Cα secondary chemical shift value of 
3.1 for a fully formed helix [31]), the estimated fraction of formed helix α1, α2, and α3 in 
LcrG is 36%, 63%, and 50%, respectively (Supplementary Information Fig. S1). In other 
words, the fractional helicity of the three helices of LcrG is not uniform – helix α2 is 
relatively the most formed helix, while helix α1 is the least formed helix of LcrG.
LcrG backbone dynamics
The steady state heteronuclear {1H}-15N NOE and 15N backbone relaxation rates (R1 and 
R2) were acquired to assess the backbone dynamics of LcrG*. The heteronuclear {1H}-15N 
NOEs provide a measure of fast backbone dynamics at the picosecond to nanosecond time 
scale and the values of {1H}-15N NOEs qualitatively describe backbone flexibility. 
Heteronuclear {1H}-15N NOE values above 0.6 are found in residues that form well-ordered 
structures and can be comparatively described as having rigid backbone flexibility; values 
below 0.2 have random coil flexibility; and those between 0.4–0.6 have semi-rigid 
flexibility. The extreme terminal residues of LcrG* (D7 and R73) showed random coil 
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flexibility with {1H}-15N NOE values below 0.2 (Fig. 6a). Most of the residues in the α-
helices showed semi-rigid flexibility with {1H}-15N NOEs values between 0.4–0.6 (Fig. 6a). 
There were a few residues in the beginning of α-helix 1 (E8, D10, K11, K14, Ala-19) and 
one in the extreme end of helix α3 (E72) that displayed higher flexibility as indicated by 
their {1H}-15N NOE values of below 0.4 (Fig. 6a). There were also residues in all the three 
α-helices (K28, L29, Ala-43, E66 and R69) with {1H}-15N NOE values above 0.6 
suggesting these residues have backbone flexibility approaching those found in well-ordered 
protein structures. Additionally, residues at the linker regions between the helices displayed 
{1H}-15N NOE values above 0.4, suggesting these loop regions are not random coil in 
flexibility but have backbone flexibility similar to the helical regions.
The 15N backbone relaxation rates (R1 and R2) indicated that the α-helices behaved with 
nearly similar backbone dynamics. There were no drastic changes in the R1 rates throughout 
the entire length of LcrG* suggesting that the protein, despite not having a well-ordered 
structure, tumbles as a single unit similar to what is observed for R1’s of well-ordered 
protein domains. Regarding the R2 rates, residues 50-53 within the linker region between 
helix α2 and helix α3 showed a uniform decrease in R2 and an increase in R1 (Fig. 6b and 
Fig. 6c). The penultimate residue of helix α1 (I37) and the linker residue K57 showed 
increased R2 without a corresponding increase in R1. This suggested chemical exchange on 
the μs-ms timescale for I37 and K57 (Fig. 6b and Fig. 6c). Excluding these two residues, the 
R2 relaxation rates remained almost uniform throughout the protein.
NMR titrations of 15N-labeled LcrG with LcrV
We used NMR chemical shift perturbation to characterize the interaction of LcrG and LcrV. 
Upon titration with LcrV, the N-terminal 2/3 of LcrG* from residues 7-51 showed 
progressive reduction in peak intensities indicating complex formation at an intermediate 
exchange time scale (Fig. 7a). The remaining C-terminal 1/3 of LcrG*, from residues 52-73 
(except residue 61), were in slow exchange and appeared as new peaks (marked with 
asterisks in Fig. 7a) upon complex formation. The new slow exchange peaks were identified 
by 3D NMR datasets using a 1:1.2 molar ratio complex of 15N/13C LcrG* with unlabeled 
LcrV. The weighted 1H,15N chemical shift perturbations of residues 52-73 are shown in 
Supplementary Information Fig. S2. Slow exchange peaks are associated with tight-binding 
interactions (typically with nanomolar kd), whereas intermediate exchange peaks are 
associated with weak-binding interactions (typically with micromolar kd). Thus, NMR 
titrations suggested that there are two binding events when LcrG* interacts with LcrV. One 
binding event is characterized by stronger interaction involving the C-terminal LcrG* 
residues 52-73, and the other binding event is characterized by weaker interaction involving 
the N-terminal LcrG* residues 7-51.
NMR titrations of ILV-labeled LcrG with LcrV
We used ILV-labeled LcrG* (where the methyl groups of isoleucine, leucine, and valine 
were 13C-labeled) in NMR titrations with LcrV. We assigned the 5 isoleucine 13Cδ1 methyl 
groups and the valine 13Cγ methyl groups of LcrG by mutagenesis, however, the leucine 
methyl groups could not be assigned by mutagenesis because of the significant number of 
overlapping peaks. Upon titration with LcrV, all the five isoleucines (I20, I37, I47, I56 and 
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I67) and the lone valine (V44) of LcrG* showed reduction in peak intensities (Fig. 8a and 
Fig. 8b). In addition, two new slow-exchange peaks appeared in the isoleucine methyl 
region (Fig. 8a). Results of 15N titration of LcrG* with LcrV (Fig. 7b) showed that the 
LcrG* region spanning residues 52-73, which contained two isoleucine residues I56 and I67, 
was in slow-exchange. Thus, the two slow-exchange peaks in the ILV-titration of LcrG with 
LcrV were most likely I56 and I67. The results of ILV-titration suggested that the methyl 
groups, hence, hydrophobic contacts, were involved in the LcrG-LcrV complex formation.
NMR titrations of isoleucine 13C-methyl labeled LcrV with LcrG* and LcrGFL
To determine the effect of LcrG truncation with respect to binding to LcrV, LcrV labeled 
with isoleucine 13Cδ1 methyl group was titrated with unlabeled LcrG* or LcrGFL C34S. 
Although the isoleucine 13Cδ1 methyl groups of LcrV have not been assigned, notably the 
same set of Ile residues of LcrV were perturbed upon binding to both LcrG* and LcrGFL 
C34S. In both in LcrG* (Fig. 8c) and LcrGFL C34S (Fig. 8d) there were four peaks that 
appeared in new positions (Fig. 8c and Fig. 8d), and same peaks underwent significant 
reduction in intensities. Thus, the truncation of LcrG did not affect the ability of LcrG to 
bind to LcrV.
Yop secretion assay
A Yop secretion assay was used to evaluate the functional significance of mutations in 
LcrG. Exogenous LcrG was expressed from a pBad18 vector and assayed for its function in 
regulating Yop secretion in Y. pestis. For wild type LcrG, Y. pestis secretes YopM only in 
the absence of Ca2+, whereas a null LcrG strain (ΔlcrG) secretes YopM constitutively in the 
presence and absence of Ca2+. The LcrG C34S or C34A mutation successfully 
complemented a ΔlcrG null strain of Y. pestis, restoring Ca+2 regulated secretion of YopM 
(Fig. 9a), indicating that the LcrG C34S or C34A mutation behaved like wild type LcrG.
Based on the observation from the NMR titration experiments that S52 to R73 of LcrG 
represented the tight-binding region for complex formation with LcrV, the Yop secretion 
assay was also used to evaluate the functional significance of this region in Y. pestis. The 
basis for this experiment is that LcrG-LcrV complex formation is necessary for the Ca2+-
regulated secretion of YopM [9,13]; whereas disruption of LcrG-LcrV complex formation 
results in constitutive YopM secretion in the presence or absence of Ca2+ [9,13]. The 
following LcrG mutations were used in the Yop secretion assay: a deletion of the entire 
region (Δ52-73), four mini deletion mutants (Δ52-57, Δ58-62, Δ63-67 and Δ68-73), and 
point mutations in I56, K57, R61, L63, I67 and K68. The point mutations were introduced 
on the basis of secondary structure predictions, which indicated that the region 52-73 formed 
an amphipathic helix with residues I56, L63, and I67 forming a hydrophobic surface, and on 
the other face of the helix, residues K57, R61 and K68 forming a hydrophilic surface. Point 
mutations were designed to alter the hydrophobicity, polarity or charge (i.e. I56N, K57L or 
K57E). The larger deletion (Δ52-73) and the mini deletions of 4 to 5 residues did not 
compromise LcrG expression and resulted in constitutive Yop secretion, with the exception 
of the most C terminal one (Δ68-73). Point mutations within these small deletions did not 
affect Yop secretion except L63N. The loss or significant decrease in expression of LcrG 
L63N could potentially result in this loss of calcium regulation. However, with the exception 
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of L63N all other point mutants showed LcrG expression. The visible band in Fig. 9b with 
the LcrG antibody used against the ΔLcrG variant is the LcrG(Δ39-53) protein that is 
expressed from the ΔlcrG on pCD1. These results suggest that deleting 4 to 5 amino acid 
segments within the region spanning 52-67 is necessary for disrupting the Ca2+-regulated 
secretion of YopM. Additionally it also suggests that the region 52-67 in LcrG is important 
in blocking the secretion of Yop effectors.
DISCUSSION
There are currently no atomic structures for any member of the LcrG family (Fig. 1) of tip 
chaperone proteins. Full length LcrG was unsuitable for NMR studies (Fig. 3), however, a 
shorter construct, LcrG* (LcrG7-73 C34S) lacking the predicted flexible tails was suitable 
for NMR characterization (Fig. 4). The C34S mutation did not alter the wild type function of 
LcrG in regulating the Ca+2 dependent secretion of YopM in Y. pestis (Fig. 9) but it 
prevented the non-specific oligomerization of LcrG via disulfide bonds that made wild type 
LcrG unsuitable for NMR studies. The secondary structures of full length LcrG were also 
present in LcrG* based on CD spectroscopy (Fig. 2). Full length LcrG and LcrG* bound to 
the same surface of LcrV as suggested by results of NMR titrations using LcrV with 13C-
methyl labeled isoleucines as probes (Fig. 8). LcrG* included the minimum region (residues 
7-40) that was identified by others to be required for interaction with LcrV [13]. Currently, 
LcrG* is the most suitable construct for NMR characterization that allows structural insights 
into the LcrG family of tip chaperones.
The hypothesis in the literature is that LcrG forms a coiled-coil [12,20], however, our CD 
(Fig. 2) and NMR data (Fig. 5) in combination show that LcrG lacks a tertiary structure and 
contains only alpha helical secondary structures (Fig. 5). The Cα chemical shifts identified 
the alpha helical regions of LcrG (Fig. 5). Overall, the α-helices in LcrG were more flexible 
compared to alpha helices found in proteins with well-defined tertiary structures (Fig. 6). 
However, there were residues in all the three α-helices whose backbone dynamics 
approached those seen in more stable helices of proteins with well-defined tertiary 
structures. Despite lacking a tertiary structure, the helices of LcrG tumble with the same R1 
and R2 rates (Fig. 6) as opposed to the helices tumbling with different rates or flapping 
around. This suggests that the interhelical regions of LcrG are not random coil in flexibility. 
NMR data best describe LcrG as a partially folded alpha helical protein, and its flexibility 
suggests that crystallization is likely difficult..
The partially folded nature of LcrG is also seen among other T3SS chaperones, where 
structural disorder specifically contributes to their function [32]. For example, CesAB from 
the enteropathogenic E. coli, a chaperone for the needle filament protein EspA is also an 
alpha helical protein with a poorly packed helical bundle, like LcrG. Upon binding to EspA, 
CesAB acquires a well-folded conformation. Interestingly though, stabilization of the 
conformation of CesAB by correcting the packing defects of the coiled coil, leads to a non-
functional T3SS. This example clearly indicates the importance of structural flexibility in 
achieving function. Additionally other T3SS chaperones like SseA and EscC from different 
bacterial species also display similar partially folded conformations [32]. Thus, proteins with 
highly dynamic conformations play important roles in type III secretion. Such intrinsically 
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flexible proteins are also seen among some effectors and structural proteins of the T3SS 
[33,34]. Thus, our results add the LcrG tip protein chaperone into the growing list of 
disordered [33,35] or partially folded [34,36–38] proteins or domains that play important 
roles in type III secretion. The common theme among these flexible proteins that lack well-
defined structures is the disorder-to-order transition when they bind other proteins or their 
ligands. The conformational dynamics of LcrG perhaps contribute to its functional 
versatility, which is a characteristic signature of many flexible proteins [39,40]. Indeed LcrG 
binds to and functions as a chaperone for LcrV as well as a key regulator of type III 
secretion. The conformationally interchangeable nature of intrinsically flexible structures 
like LcrG likely ensures easier adaption of distinct transient states which possibly 
contributes in carrying out multiple roles within the cellular environment.
How LcrG binds to LcrV is poorly understood as there is currently no atomic structure for 
the LcrG-LcrV complex. Our NMR titrations (Fig. 7) indicate that the entire length of 
LcrG* residues 7-73 is involved in the interaction with LcrV. Our NMR results preclude a 
scenario where LcrG forms a coiled-coil upon binding to LcrV as suggested previously [12]. 
Formation of an LcrG coiled-coil would have resulted in a more dispersed 2D 1H-15N 
HSQC of LcrG compared to what we had observed (Fig. 7). Further, the secondary 13Cα 
secondary chemical shifts of the slow-exchange peaks (residues 52-63) of the complex form 
of LcrG (Supplementary Information Fig. S3) did not show an increased helicity 
(Supplementary Information Fig. S1) compared to the free form. Our titration data agrees 
with the literature that the N-terminus of LcrG is the binding site for LcrV [9,13]. However, 
our NMR titrations also indicated that the C-terminus of LcrG is involved in binding LcrV 
(Fig. 7). There can be two primary explanations for this observation. First, it is possible that 
the sheer difference in size between the two binding partners (37 kDa for LcrV and 8 kDa 
for LcrG) entails that almost the entire length of the smaller protein (LcrG) is needed to 
form a stable binding interface. Since LcrG is partially folded and intrinsically flexible, it is 
highly likely that LcrG entwines around LcrV. This is not uncommon since many flexible 
proteins present a larger surface area for interaction as compared to globular proteins [39].
The deletion mutants (Δ52-57, Δ58-62, Δ63-67 and Δ52-73) and the one point mutant, L63N 
showed a defect in the secretion blocking activity of LcrG (Fig. 9). The rest of the point 
mutants (I56N, K57E, K57L, R61E, R61L, I67N, K68E and K68L) and one deletion mutant, 
Δ68-73, behaved as wild type LcrG. Thus, NMR results plus the results of the Yop secretion 
assay suggest that the region S52 to I67 in LcrG plays an important role in blocking the 
secretion of Yop effectors. Results of Matson and coworkers [13] suggested that the residue 
F48 in LcrG, is involved in blocking the secretion of Yops. Our results are further 
corroborated by studies on the homolog, PcrG, which implicated that the C-terminus of 
PcrG is important in blocking the secretion of effector proteins [41]. Additionally, it is also 
possible that the LcrV binding and secretion blocking regions of LcrG overlap, and hence 
none of the mutants could block secretion of YopM.
In summary, NMR and CD data show that LcrG is a partially folded α-helical protein that 
lacks a tertiary structure, and that the entire length of LcrG residues 7-73 is involved in the 
interaction with LcrV.
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Protein expression and purification
The coding regions of Y. pestis LcrGFL (full length version spanning residues 1-95) and 
LcrG7-73 (the truncated form spanning residues 7-73) were PCR amplified from pCD1 [42] 
and subcloned into the pET-21a expression vector using NdeI and BamHI as the restriction 
sites. The vector was modified to encode an N-terminal His6-tagged GB1 domain followed 
by a tobacco etch virus (TEV) protease site. GB1 (56 residues) is the B1 immunoglobulin 
binding domain from Streptococcus protein G that functions as a solubility enhancement tag 
[43,44]. For protein expression, plasmids were transformed in E. coli BL21 (DE3) DNAY 
cells and colonies were picked to inoculate a starter culture of 50 mL LB with kanamycin 
and carbenicillin as antibiotics and grown overnight at 37 °C. Unlabeled proteins were 
obtained by using the 50ml LB starter culture to inoculate 1 L LB. Isotopically 15N 
and 15N/13C labeled proteins were obtained by pelleting the 50 mL LB starter culture, and 
using it to inoculate a 1 L M9 minimal media with 1 g/L of 15N-ammonium chloride (Isotec) 
and/or 2 g/L of 13C-glucose (Isotec). Cells were grown at 37 °C until the A600 was ~ 0.6 to 
0.8, induced with 1 mM isopropyl-β-D-thiogalactopyranoside and cell growth was continued 
at 15 °C overnight in a shaker-incubator to a final A600 ~2.0. Cells were harvested by 
centrifugation and resuspended in 30 mL binding buffer (500 mM NaCl, 20 mM Tris-HCl, 5 
mM imidazole, pH 8.0). For protein purification, cells were sonicated in the presence of 
~300 μl of 1 mM phenylmethylsulfonyl fluoride. Cellular debris was removed by 
centrifugation of the cell lysate and 600 μl of 5% polyethyleneimine was added to the 
supernatant to precipitate the nucleic acids. Following centrifugation, the supernatant was 
loaded onto a Ni2+-affinity column (Sigma), that was previously treated with 35 mL water, 
35 ml 50mM NiSO4 and 35 ml binding buffer. The Ni2+-column was washed with 100 ml of 
binding buffer and the fusion proteins were eluted using ~60 mL of elution buffer (250 mM 
imidazole, 500 mM NaCl, 20 mM Tris, pH 8.0). The purified fusion protein fractions were 
combined and dialyzed overnight at room temperature in 1 L of TEV buffer (50mM Tris, 0.5 
mM EDTA, 1mM DTT, 20 mM NaCl, pH 8.0) in the presence of 250 uL of 0.06 mM 
recombinant TEV protease [45]. The digested protein mixture was dialyzed again in I L 
binding buffer. The digest was loaded onto a Ni2+-affinity column, which retained the GB1 
tag and eluted the purified proteins. After TEV protease digestion, all LcrV and LcrG 
protein constructs used herein retained a three-residue cloning artifact “GHM” at their N-
termini. Purified proteins were dialyzed in NMR buffer (10 mM NaPO4, 10 mM NaCl, pH 
7.0) and concentrated using Amicon Ultra 3K (Millipore). Protein concentrations were 
estimated by absorbance at A280.
Site-directed mutations were generated using the Stratagene QuickChange kit. LcrV 
spanning residues 28-322 in a C273S background mutation was expressed and purified as 
described previously [18]. 15N amino acid specific labeling of isoleucine and phenylalanine 
was done following a published protocol [46].
ILV labeling
Specific 13C-labeling of the methyl groups of isoleucine (I), leucine (L) and valine (V) in 
LcrG and LcrV was done using 13C-labeled α-keto acids as precursors following published 
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protocols [47]. The Cδ1 methyl group of isoleucine was 13C-labeled by using 2-keto-3-
(methyl-13C)-butyric acid-4-13C (Isotec # 571334); whereas the two leucine Cδ and the two 
valine Cγ methyl groups were 13C-labeled by using 2-keto-3-(methyl-13C)-butyric 
acid-4-13C (Isotec # 571334). The α-keto acids were added to the minimal media when cell 
growth reached an A600 of 0.4 ~ 0.5. After 45–60 minutes the cultures were induced with 
1.0 mM IPTG and cell growth was continued in a 15 °C shaker incubator overnight. Cells 
were harvested the following morning and proteins were purified as described above. LcrG* 
was ILV-labeled whereas LcrV was only labeled with the isoleucine 13Cδ1 methyl group. 
The isoleucine 13Cδ1 and the two valine 13Cγ methyl groups of LcrG* were assigned by 
mutagenesis using alanine point mutations (in I20, I37, I47, I56, I67, and V44) and 
2D 1H-13C HSQC spectrum of ILV-labeled LcrG was acquired for each mutant.
CD spectroscopy
Samples for circular dichroism spectroscopy contained 1–2 μM protein samples in buffer 
(10 mM NaPO4, 10 mM NaCl, pH 7.0). CD spectra were acquired in triplicate using a 
JASCO J-815 Spectropolarimeter. Wavelength scans were collected at 20 °C at a scan rate 
of 50 nm/min. Thermal denaturation curves were monitored at 222 nm at a temperature 
ramp rate of 2 °C/min.
NMR Spectroscopy
NMR data were acquired at 25 °C using a Bruker Avance 800 MHz spectrometer equipped 
with a cryogenic triple resonance probe, processed with NMRPipe [48], and analyzed by 
NMRView [49]. Two-dimensional 1H-15N HSQC spectra [50] were acquired using 0.5–0.8 
mM of protein samples. For backbone assignments of LcrG, 15N/13C LcrG* (0.9 mM) was 
used to acquire 2D 1H-15N HSQC, 3D HNCA, 3D HNCACB, and 3D CBCA(CO)NHA[50–
52] datasets. Secondary structures were identified from the Cα, and Cβ chemical shifts [28]. 
To assign the backbone resonances of LcrG in the complex, 15N/13C LcrG* (0.6 mM) was 
complexed with unlabeled LcrV at a molar ratio of 1:1.2 and 2D 1H-15N HSQC [50], 3D 
HNCA and 3D HNCACB [52] were acquired.
NMR backbone dynamics
Backbone 15N relaxation parameters (R1, R2, and steady-state heteronuclear {1H}-15N 
NOE) were acquired using a 0.7 mM 15N LcrG* sample in NMR buffer. The steady-state 
heteronuclear {1H}-15N NOE was acquired as described in [53] with 2048 (1H) * 128 (15N) 
complex points, 60 scans per point and a 5 sec recycle delay. The heteronuclear {1H}-15N 
NOE was calculated as the ratio of intensities of each peak in the two 2D datasets [53]. Error 
bars were estimated using the standard deviation of the background signal of each spectrum. 
The 15N backbone relaxation rates R1 and R2 were acquired as described [54]. The time 
delays used to determine R1 were 10, 60, 120, 240, 400, 900 and 1100 ms, and the time 
delays used to determine R2 were 20, 40, 50, 60, 70, 90, 100, 120 and 150 ms. Peak 
intensities were obtained using NMRView [49] and fitted using GNUPLOT [55]. Deviations 
from fitting were reported as error bars. Due to peak overlap, residues 9, 47, 64, 33, 36, 27, 
28, 15, 42 and 70 were not used in the analysis. Residues 15, 54 and 61 could not be 
resolved, and hence were not used in the analysis.
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NMR chemical shift mapping
Protein samples were dialyzed in the same NMR buffer and 2D 1H-15 N HSQC spectra were 
acquired for 15N-labeled samples and 2D 1H-13C HSQC spectra were acquired for 13C-
methyl-labeled samples. 15N-labeled LcrG* (0.2 mM) was titrated with increasing amounts 
of unlabeled LcrV in molar ratios of 1:0, 1:0.5, 1:1.2, 1:2, 1:3, 1:4 and 1:6.5. Likewise, 13C-
ILV labeled LcrG* (0.36 mM) was titrated with increasing amounts of unlabeled LcrV in 
molar ratios of 1:0, 1:0.25, 1:0.5, 1:1 and 1:2. Additionally, isoleucine 13Cδ1-labeled LcrV 
(0.36 mM) was titrated with unlabeled LcrG* or unlabeled LcrGFL C34S in molar ratios of 
1:0, 1:0.25, 1:0.5, 1:1 and 1:2.
Yop secretion assay
LcrG expression vectors were electroporated into the lcrG deletion mutant Y. pestis 
KIM5-3001.5. This strain contains an in-frame non-polar deletion of plasmid pCD1 
sequences encoding LcrG residues 39 to 53 or LcrG(Δ39-53). This mutant secretes the Yop 
effector proteins constitutively in the presence and absence of calcium (calcium blind 
phenotype) and can be complemented back to the wild type calcium-regulated secretion 
phenotype by providing lcrG in trans. The LcrG proteins were expressed from a pBAD18 
vector, induced with 0.2% L-(+)-arabinose upon shifting the temperature from 27 °C to 37 
°C and normalized using the optical density (OD620) of the cultures at harvest. Fractions 
were collected after 5 hours incubation at 37 °C. Levels of YopM in both whole cells and 
culture supernatant were analyzed by immunoblotting with anti YopM polyclonal 
antibodies. The levels of LcrG were also monitored in whole cells by immunoblotting with 
anti LcrG antibodies. LcrG C34S, LcrG C34A, and several mutants of the LcrG 52-73 
region (deletion mutants Δ52-57, Δ58-62, Δ63-67, Δ68-73, Δ52-73; and point mutants I56N, 
K57E, K57L, R61E, R61L, L63N, I67N, K68E, and K68L) were tested by the Yop secretion 
assay.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
Supported by NIH grants AI101823 (G.V.P), AI074856 (R.N.D.), and P30GM110761 (University of Kansas 
BioNMR Core Facility). We are grateful to Dr. Asokan Anbanandam for technical assistance in the NMR 
experiments.
Abbreviations
NMR nuclear magnetic resonance
LcrG* LcrG residues 7-73 C34S
LcrGFL full length LcrG
T3SS type III secretion system
Chaudhury et al. Page 11














1. Cornelis GR. Yersinia type III secretion: send in the effectors. J Cell Biol. 2002; 158:401–408. 
[PubMed: 12163464] 
2. Cornelis GR. The Yersinia Ysc-Yop ‘type III’ weaponry. Nat Rev Mol Cell Biol. 2002; 3:742–752. 
[PubMed: 12360191] 
3. Burkinshaw BJ, Strynadka NC. Assembly and structure of the T3SS. Biochim Biophys Acta. 2014; 
1843:1649–1663. [PubMed: 24512838] 
4. Chatterjee S, Chaudhury S, McShan AC, Kaur K, De Guzman RN. Structure and biophysics of type 
III secretion in bacteria. Biochemistry. 2013; 52:2508–2517. [PubMed: 23521714] 
5. Galan JE, Lara-Tejero M, Marlovits TC, Wagner S. Bacterial type III secretion systems: specialized 
nanomachines for protein delivery into target cells. Annu Rev Microbiol. 2014; 68:415–438. 
[PubMed: 25002086] 
6. Cornelis GR. The type III secretion injectisome. Nat Rev Microbiol. 2006; 4:811–825. [PubMed: 
17041629] 
7. Mueller CA, Broz P, Muller SA, Ringler P, Erne-Brand F, Sorg I, et al. The V-antigen of Yersinia 
forms a distinct structure at the tip of injectisome needles. Science. 2005; 310:674–676. [PubMed: 
16254184] 
8. DeBord KL, Lee VT, Schneewind O. Roles of LcrG and LcrV during type III targeting of effector 
Yops by Yersinia enterocolitica. J Bacteriol. 2001; 183:4588–4598. [PubMed: 11443094] 
9. Matson JS, Nilles ML. LcrG-LcrV interaction is required for control of Yops secretion in Yersinia 
pestis. J Bacteriol. 2001; 183:5082–5091. [PubMed: 11489861] 
10. Fields KA, Nilles ML, Cowan C, Straley SC. Virulence role of V antigen of Yersinia pestis at the 
bacterial surface. Infect Immun. 1999; 67:5395–5408. [PubMed: 10496922] 
11. Nilles ML, Williams AW, Skrzypek E, Straley SC. Yersinia pestis LcrV forms a stable complex 
with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response. J Bacteriol. 
1997; 179:1307–1316. [PubMed: 9023216] 
12. Lawton DG, Longstaff C, Wallace BA, Hill J, Leary SE, Titball RW, et al. Interactions of the type 
III secretion pathway proteins LcrV and LcrG from Yersinia pestis are mediated by coiled-coil 
domains. J Biol Chem. 2002; 277:38714–38722. [PubMed: 12107165] 
13. Matson JS, Nilles ML. Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV 
occurs at a hydrophobic interface. BMC Microbiol. 2002; 2:16. [PubMed: 12102728] 
14. Hamad MA, Nilles ML. Roles of YopN, LcrG and LcrV in controlling Yops secretion by Yersinia 
pestis. Adv Exp Med Biol. 2007; 603:225–234. [PubMed: 17966419] 
15. Straley SC, Plano GV, Skrzypek E, Haddix PL, Fields KA. Regulation by Ca2+ in the Yersinia 
low-Ca2+ response. Mol Microbiol. 1993; 8:1005–1010. [PubMed: 8361348] 
16. Skrzypek E, Straley SC. LcrG, a secreted protein involved in negative regulation of the low-
calcium response in Yersinia pestis. J Bact. 1993; 175:3520–3528. [PubMed: 8501055] 
17. Sarker MR, Sory MP, Boyd AP, Iriarte M, Cornelis GR. LcrG is required for efficient translocation 
of Yersinia Yop effector proteins into eukaryotic cells. Infect Immun. 1998; 66:2976–2979. 
[PubMed: 9596775] 
18. Chaudhury S, Battaile KP, Lovell S, Plano GV, De Guzman RN. Structure of the Yersinia pestis 
tip protein LcrV refined to 1. 65 Å resolution. Acta Crystallogr Sect F. 2013; 69:477–481.
19. Derewenda U, Mateja A, Devedjiev Y, Routzahn KM, Evdokimov AG, Derewenda ZS, et al. The 
structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity 
against plague. Structure. 2004; 12:301–306. [PubMed: 14962390] 
20. Pallen MJ, Dougan G, Frankel G. Coiled-coil domains in proteins secreted by type III secretion 
systems. Mol Microbiol. 1997; 25:423–425. [PubMed: 9282753] 
21. Blocker AJ, Deane JE, Veenendaal AK, Roversi P, Hodgkinson JL, Johnson S, et al. What’s the 
point of the type III secretion system needle? Proc Natl Acad Sci USA. 2008; 105:6507–6513. 
[PubMed: 18458349] 
Chaudhury et al. Page 12













22. Basu A, Das U, Dey S, Datta S. PcrG protects the two long helical oligomerization domains of 
PcrV, by an interaction mediated by the intramolecular coiled-coil region of PcrG. BMC Struct 
Biol. 2014; 14:5. [PubMed: 24460624] 
23. McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. 
Bioinformatics. 2000; 16:404–405. [PubMed: 10869041] 
24. Kiss RS, Kay CM, Ryan RO. Amphipathic alpha-helix bundle organization of lipid-free chicken 
apolipoprotein A-I. Biochemistry. 1999; 38:4327–4334. [PubMed: 10194351] 
25. Lau SY, Taneja AK, Hodges RS. Synthesis of a model protein of defined secondary and quaternary 
structure. Effect of chain length on the stabilization and formation of two-stranded alpha-helical 
coiled-coils. J Biol Chem. 1984; 259:13253–13261. [PubMed: 6490655] 
26. Choy N, Raussens V, Narayanaswami V. Inter-molecular coiled-coil formation in human 
apolipoprotein E C-terminal domain. J Mol Biol. 2003; 334:527–539. [PubMed: 14623192] 
27. Wang Y, Boudreaux DM, Estrada DF, Egan CW, StJeor SC, De Guzman RN. NMR structure of 
the N-terminal coiled-coil domain of the Andes hantavirus nucleocapsid protein. J Biol Chem. 
2008; 283:28297–28304. [PubMed: 18687679] 
28. Wishart DS, Nip AM. Protein chemical shift analysis: a practical guide. Biochem Cell Biol. 1998; 
76:153–163. [PubMed: 9923684] 
29. Kim MK, Kang YK. Positional preference of proline in alpha-helices. Protein Sci. 1999; 8:1492–
1499. [PubMed: 10422838] 
30. Eliezer D, Yao J, Dyson HJ, Wright PE. Structural and dynamic characterization of partially folded 
states of apomyoglobin and implications for protein folding. Nat Struct Biol. 1998; 5:148–155. 
[PubMed: 9461081] 
31. Bax A, Spera S. Empirical Correlation between Protein Backbone Conformation and Cα and Cβ 
13C Nuclear Magnetic Resonance Chemical Shifts. J Am Chem Soc. 1991; 113:5490–5492.
32. Chen L, Balabanidou V, Remeta DP, Minetti CA, Portaliou AG, Economou A, et al. Structural 
instability tuning as a regulatory mechanism in protein-protein interactions. Mol Cell. 2011; 
44:734–744. [PubMed: 22152477] 
33. Rodgers L, Gamez A, Riek R, Ghosh P. The type III secretion chaperone SycE promotes a 
localized disorder-to-order transition in the natively unfolded effector YopE. J Biol Chem. 2008; 
283:20857–20863. [PubMed: 18502763] 
34. Zhong D, Lefebre M, Kaur K, McDowell MA, Gdowski C, Jo S, et al. The Salmonella type III 
secretion system inner rod protein PrgJ is partially folded. J Biol Chem. 2012; 287:25303–25311. 
[PubMed: 22654099] 
35. Salomon D, Guo Y, Kinch LN, Grishin NV, Gardner KH, Orth K. Effectors of animal and plant 
pathogens use a common domain to bind host phosphoinositides. Nat Commun. 2013; 4:2973. 
[PubMed: 24346350] 
36. Weise CF, Login FH, Ho O, Grobner G, Wolf-Watz H, Wolf-Watz M. Negatively charged lipid 
membranes promote a disorder-order transition in the Yersinia YscU protein. Biophys J. 2014; 
107:1950–1961. [PubMed: 25418176] 
37. Chen L, Ai X, Portaliou AG, Minetti CA, Remeta DP, Economou A, et al. Substrate-activated 
conformational switch on chaperones encodes a targeting signal in type III secretion. Cell Rep. 
2013; 3:709–715. [PubMed: 23523349] 
38. Hamada D, Kato T, Ikegami T, Suzuki KN, Hayashi M, Murooka Y, et al. EspB from 
enterohaemorrhagic Escherichia coli is a natively partially folded protein. FEBS J. 2005; 272:756–
768. [PubMed: 15670156] 
39. Babu MM, van der Lee R, de Groot NS, Gsponer J. Intrinsically disordered proteins: regulation 
and disease. Curr Opin Struct Biol. 2011; 21:432–440. [PubMed: 21514144] 
40. Wright PE, Dyson HJ. Linking folding and binding. Curr Opin Struct Biol. 2009; 19:31–38. 
[PubMed: 19157855] 
41. Lee PC, Stopford CM, Svenson AG, Rietsch A. Control of effector export by the Pseudomonas 
aeruginosa type III secretion proteins PcrG and PcrV. Mol Microbiol. 2010; 75:924–941. 
[PubMed: 20487288] 
Chaudhury et al. Page 13













42. Perry RD, Straley SC, Fetherston JD, Rose DJ, Gregor J, Blattner FR. DNA sequencing and 
analysis of the low-Ca2+-response plasmid pCD1 of Yersinia pestis KIM5. Infect Immun. 1998; 
66:4611–4623. [PubMed: 9746557] 
43. Huth JR, Bewley CA, Jackson BM, Hinnebusch AG, Clore GM, Gronenborn AM. Design of an 
expression system for detecting folded protein domains and mapping macromolecular interactions 
by NMR. Protein Sci. 1997; 6:2359–2364. [PubMed: 9385638] 
44. Zhou P, Wagner G. Overcoming the solubility limit with solubility-enhancement tags: successful 
applications in biomolecular NMR studies. J Biomol NMR. 2010; 46:23–31. [PubMed: 19731047] 
45. Geisbrecht BV, Bouyain S, Pop M. An optimized system for expression and purification of 
secreted bacterial proteins. Protein Expr Purif. 2006; 46:23–32. [PubMed: 16260150] 
46. Wang Y, Nordhues BA, Zhong D, De Guzman RN. NMR characterization of the interaction of the 
Salmonella type III secretion system protein SipD and bile salts. Biochemistry. 2010; 49:4220–
4226. [PubMed: 20397637] 
47. Tugarinov V, Kanelis V, Kay LE. Isotope labeling strategies for the study of high-molecular-
weight proteins by solution NMR spectroscopy. Nat Protoc. 2006; 1:749–754. [PubMed: 
17406304] 
48. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional 
spectral processing system based on UNIX pipes. J Biomol NMR. 1995; 6:277–293. [PubMed: 
8520220] 
49. Johnson BA. Using NMRView to visualize and analyze the NMR spectra of macromolecules. 
Methods Mol Biol. 2004; 278:313–352. [PubMed: 15318002] 
50. Grzesiek S, Bax A. The importance of not saturating H2O in protein NMR. Application to 
sensitivity enhancement and NOE measurements. J Am Chem Soc. 1993; 115:12593–12594.
51. Grzesiek S, Bax A. Correlating backbone amide and side chain resonances in larger proteins by 
multiple relayed triple resonance NMR. J Am Chem Soc. 1992; 114:6291–6293.
52. Wittekind M, Mueller L. HNCACB, a high sensitivity 3D NMR experiment to correlate amide 
proton and nitrogen resonances with the alpha-carbon and beta-carbon resonances in proteins. J 
Magn Reson. 1993; 101B:201–205.
53. Stone MJ, Fairbrother WJ, Palmer AG III, Reizer J, Saier MH Jr, Wright PE. Backbone dynamics 
of the Bacillus subtilis glucose permease IIA domain determined from 15N NMR relaxation 
measurements. Biochemistry. 1992; 31:4394–4406. [PubMed: 1316146] 
54. Farrow NA, Muhandiram R, Singer AU, Pascal SM, Kay CM, Gish G, et al. Backbone dynamics 
of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. 
Biochemistry. 1994; 33:5984–6003. [PubMed: 7514039] 
55. Williams, T.; Kelley, C. Gnuplot 4.4: an interactive plotting program. 2010. http://
gnuplot.sourceforge.net/
56. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive 
multiple sequence alignment through sequence weighting, position-specific gap penalties and 
weight matrix choice. Nucleic Acids Res. 1994; 22:4673–4680. [PubMed: 7984417] 
Chaudhury et al. Page 14














• LcrG-LcrV interaction is important in the pathogenesis of Yersinia pestis.
• The atomic structure of the LcrG protein family is unknown.
• NMR shows that LcrG is a partially folded alpha helical protein.
• NMR identified a C-terminal region of LcrG that binds tightly to LcrV.
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Sequence alignment of LcrG family of T3SS tip chaperones. The predicted helical regions 
by PSIPRED [23] are shown as well as the helical regions identified by NMR. Solid blue 
lines indicate the regions of tight-binding interaction with LcrV identified by yeast two 
hybrid [13] and by NMR. The proteins used in the alignment by CLUSTALW [56] are LcrG 
(Yersinia pestis), LcrG (Yersinia enterocolitica), PcrG (from two strains of Pseudomonas 
aeruginosa), LssG (Photorhabdus asymbiotica) and AcrG (Aeromonas hydrophila).
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CD and thermal denaturation spectra of the various LcrG constructs. CD spectra were 
acquired for (a) LcrGFL, (b) LcrG7-73, and (c) LcrG* (LcrG7-73 C34S). Thermal 
denaturation plots of (d) LcrGFL, (e) LcrG7-73, and (f) LcrG*. (Molar ellipticity θ = 
(deg·cm2·dmol−1) ×10−5).
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Two-dimensional 1H-15N HSQC spectra of (a) LcrGFL (b) LcrGFL C34S, (c) LcrG7-73 and 
(d) LcrG7-73 C34A, and (e) LcrG* (LcrG7-73 C34S).
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Assigned 2D 1H-15N HSQC spectrum of LcrG*. Overlapped peaks are marked with asterisk. 
The intensity for the peak of E54 is weak, its position is indicated by ‘+’.
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Secondary (a) 13Cα and (b) 13Cβ chemical shifts of LcrG*. Helical regions identified by the 
secondary chemical shifts are indicated.
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Backbone dynamics of LcrG*. (a) Heteronuclear {1H}-15N NOEs, and relaxation rates (b) 
R1 and (c) R2 for LcrG*. The helical regions are shaded. Gaps in the data are due to 
overlapped peaks or missing assignments.
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NMR titrations of 15N LcrG* with LcrV. (a) Seven overlaid 2D 1H-15N HSQC spectra of 
LcrG* with increasing molar ratios of LcrV. Backbone amide peaks that appeared in new 
positions upon complex formation are marked with asterisks. The rest of the backbone 
amide peaks showed significant reduction in peak intensities. (b) Assigned 2D 1H-15N 
HSQC spectrum of the LcrG*-LcrV complex. Backbone amide peaks of residues S52 to 
R73 appeared in new positions upon complex formation. The original peak positions of 
these residues are indicated. Blue arrows point to the new peak positions (shown in red). The 
prefix “1” has been added to indicate LcrG residue number in complex with LcrV. The red 
asterisks indicate the complex peaks for S52 and E54 whose intensities were too low to 
appear on the contour level of the spectrum shown.
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Titrations of 13C ILV-labeled LcrG* with LcrV showing the 13C methyl region of (a) 
isoleucine (ILE), and (B) leucine and valine (LV). The prefix “1” has been added to indicate 
LcrG residue number in complex with LcrV. The assignment of the complex peaks of I56 
and I67 presented in (a) are based on the exchange behavior observed for 1H/15N 
correlations. Titrations of 13C isoleucine-labeled LcrV with (c) LcrG* and (d) full length 
LcrG C34S. Slow exchange peaks are boxed and intermediate exchange peaks are marked 
with asterisk. A slow exchange peak in (d), marked ‘x’, has weak intensity and appears at a 
lower contour lever shown in the insert.
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Effect of LcrG mutations on YopM secretion in the presence or absence of Ca2+. Wild type 
Y. pestis KIM5-3001, the lcrG deletion strain KIM5-3001.5 (ΔlcrG) and KIM5-3001.5 
(ΔlcrG) carrying plasmid pBAD-LcrG (+LcrG), or derivatives of this plasmid carrying point 
mutations (panels a and b) or small deletions (panel b) in lcrG were grown for 1 h at 27 °C 
and for 5 h at 37 °C in the presence (+) or absence (−) of 2.5 mM CaCl2. Secreted and whole 
cell proteins were analyzed by SDS-PAGE and immunoblotting with LcrG or YopM 
antibodies (α). The location of the YopM, LcrG and LcrG(Δ39-53) bands are indicated by 
arrowheads.
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